Nobiletin is an O-methylated flavonoid found in citrus peels that have anticancer, antiviral, neuroprotective, anti-inflammatory activities and depending on the cell types exhibits both pro-or anti-apoptotic properties. We have found that nobiletin decreases oxygen consumption by bovine brain isolated mitochondria in the presence of glutamate and malate and increases in the presence of succinate. In parallel, nobiletin increases NADH oxidation, a-ketoglutarate dehydrogenase activities and through matrix substrate-level phosphorylation elevates the a-ketoglutarate-dependent production of ATP. In addition, nobiletin reduces the production of peroxides in the presence of complex I substrates and slightly enhances succinate-driven H 2 O 2 formation. Besides, nobiletin induces transient elevation of membrane potential followed by mild depolarization. Affinity purified nobiletin binding proteins revealed one major anti-NDUFV1 positive protein with 52kD and NADH: ubiquinone oxidoreductase activity. This fraction can produce peroxide that is inhibited by nobiletin. We propose that nobiletin may act as a mild "uncoupler", which through activation of a-ketoglutarate dehydrogenase (a-KGDH)-complex and acceleration of matrix substratelevel phosphorylation maintains membrane potential at an abnormal level. This switch in mitochondrial metabolism could elevate succinate-driven oxygen consumption that may underlay in both pro-and anti-apoptotic effects of nobiletin.
Many citrus flavonoids have potential health benefits, among which nobiletin attracts much attention because of its anti-inflammatory, antitumor and neuroprotective properties [1] . Nobiletin (3',4',5,6,7,8-Hexamethoxyflavone) is a major component of citrus fruits, particularly of the peels of Sweet oranges (Citrus sinensis) and mandarin oranges (Citrus reticulate). It exerts protective effects on beta-amyloid peptide-induced impairment of learning ability [2] , improves impaired memory in animal models of Alzheimer's disease and mice with brain ischemia [3, 4] ; has neuroprotective effects on ischemia-induced neuronal death in the hippocampal CA1 region [3] . In addition, nobiletin restores the olfactorybulbectomized-induced cholinergic neurodegeneration [5] and upregulates synaptic neurotransmission in the hippocampus [6] . This flavonoid could ameliorate scratching behavioral reactions in mice by inhibiting the action of histamine, as well as by the activation of the transcription factors NF-κB and AP-1 via protein kinase C [7] . Nobiletin produces an antidepressant-like effect in mice [8] and induces neurogenesis via its interactions with critical neuronal intracellular signaling pathways [9] . The neurotrophic effect of nobiletin is mediated through cAMP/ERK/MAPK/CREB-dependent mechanisms [10, 11] .
Besides neuroprotective i.e. anti-apoptotic activity, nobiletin also exhibits anti-tumor effects on human colorectal HT-29 cells, ductal breast carcinoma MDA-MB-435, adenocarcinoma MCF-7 cells and Human Caucasian gastric adenocarcinoma (AGS) cells [12, 13, 14] . It has been shown that nobiletin suppresses the proliferation of C6 rat glioma cells by the inhibition of Ras activity and subsequent reduction of MEK/ERK signaling via Ca-dependent activation of protein kinase C [15] . This pro-and anti-apoptotic effects of nobiletin on the various cells suggest that this compound acts on the central metabolic systems, such as calcium homeostasis or mitochondrial bioenergetics. The mitochondrion is a primary organelle involved in the main processes of cell viability, such as apoptosis, differentiation, and proliferation. Our previous investigation has shown that nobiletin restores impaired hippocampal mitochondrial bioenergetics in hypothyroidism through activation of matrix substrate-level phosphorylation [16] . Furthermore, it has been demonstrated that nobiletin induces mild mitochondrial depolarization and prevents mitochondrial calcium overload in neurons [17] . Besides, nobiletin transiently increases the production of nitric oxide in mitochondria that lead to a subsequent compensatory elevation of cytochrome c oxidase and succinate dehydrogenase [18] . These data suggest that mitochondrial oxidative metabolism may be the primary target for nobiletin's action. In this study, we investigated the direct action of nobiletin on the main parameters of brain mitochondrial bioenergetics.
Our experiments were initiated with the study of nobiletin's action on the respiratory rate of mitochondria. We have found that nobiletin decreases oxygen consumption supported by NAD+linked substrates (glutamate+ malate) ( Figure 1a ). Rotenone, an inhibitor of complex I, reduces the rate of oxygen consumption in control mitochondria but does not change respiration rate in nobiletin-treated mitochondria. In contrast, nobiletin increases oxygen consumption in succinate-supported mitochondria and 3nitropropionic acid, an irreversible inhibitor of complex II, reduces oxygen consumption in both, control and nobiletin-treated mitochondria ( Figure 1b 
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To test whether a decrease in oxygen consumption correlates with the changes in oxidative phosphorylation, mitochondrial ATP production was determined. Surprisingly, we have found that the ATP synthesis was increased in the presence of complex I substrates in the nobiletin-treated mitochondria (Figure 2A ), and this elevation was not sensitive to rotenone. Besides, we observed the 3-nitropropionic acid (3-NPA)-sensitive increase of ATP synthesis in control and succinate-supplied mitochondria in the presence of nobiletin. Moreover, we have detected a significant reduction of ATP synthesis in the presence complex III inhibitorantimycin A ( Figure 2B ). These data indicate that nobiletin increases ATP synthesis through both, complex I and complex II, either by its direct activation or by increasing the provision of substrates, i.e. succinate for complex II. α-Ketoglutarate dehydrogenase complex is a crucial dehydrogenase in the citric acid cycles and principal suppliers of NADH for complex I, as well as succinate for complex II [19] . This complex catalyzes the decarboxylation of alpha-ketoglutarate to succinyl-CoA coupling with the conversion of succinyl-CoA and ADP (or GDP) to CoASH, succinate, and ATP (or GTP) catalyzed by succinyl-CoA-ligase (SCL). To elucidate the involvement of these enzymes in the effects of the nobiletin, we analyzed α-KGDH and SCL activities of brain mitochondria in the presence of nobiletin. We have found that nobiletin increases α-ketoglutarate dehydrogenase activity and has no effect on the SCL (Figure 3a ). Activation α-ketoglutarate-dependent NADH-oxidation should lead to an increase in products of the coupled KGDH-SCL reaction, i.e. to the synthesis of ATP and succinate. To test this assumption, we have directly determined the a-ketoglutarate-dependent production of ATP. Analyzes of coupled KGDH-SCL reaction were performed in the presence of 3-nitropropionic acid, irreversible inhibitors of SDH (complex II) and rotenone. To eliminate the inhibition of the KGDH-SCL activity by reaction products (i.e. succinate), we analyzed only the initial step of enzymatic reactions. We have found that nobiletin markedly increases the a-ketoglutaratedependent production of ATP ( Figure 3b ). Therefore, nobiletin can accelerate ATP-synthesis by matrix substrate-level phosphorylation that should be significant for the provision of complex II by succinate.
KGDHC is a calcium-sensitive central enzyme of metabolism that produces ROS and also is controlled by them [20, 21, 22] . ROS production capacity of mitochondria mainly is controlled by Ca 2+ [23] . Therefore, at the next step, we investigated the effect of nobiletin on the production of ROS in the presence of Ca 2+ . Our finding showed that Ca 2+ at the 0.1 mM concentration increases production of ROS in the state 3 of respiration with the glutamate/malate as substrates and nobiletin decreases the production of ROS in the presence of Ca 2+ . Nobiletin slightly increases the succinate-dependent production of ROS either in the presence or/in the absence of rotenone. These data suggest that nobiletin decreases the formation of peroxides by the action on the complex I ( Figure 4 ).
Figure 4:
Effect of 10 μM nobiletin on Ca-induced peroxide production by brain mitochondria. Four independent assays were performed, and data shown are the mean ± S.D. of the means obtained from triplicates of each experiment. Analyzed by one-way ANOVA test. Furthermore, we have found that peroxide formation depends on the pre-incubation time of mitochondria with the nobiletin. In the short period of pre-incubation (3-5 min), nobiletin increases the production of ROS, whereas the prolongation of incubation (7-10 min) leads to the reduction of peroxides' formation ( Fig 5a) . This transient elevation of ROS production is accompanied by a rapid spike of mitochondrial membrane potential (Δφ m ). After nobiletin pre-treatment Δφ m sustained in the increased levels over the period of 5 min, and after that decreased below to the control level ( Figure  5b ). Since the complex I could be a primary source of peroxide, in the next experiments we studied the NADH: ubiquinone reductase activity in this time-period. We have found that 5-minute preincubation of mitochondria with flavonoid induces inhibition of NADH: ubiquinone reductase activity, whereas prolongation of preincubation up to 10 min cause activation ( Figure 6 ). Apparently, temporary alteration in peroxide production, as well as the inhibitory phase in the initial stages of NADH oxidation may be the result of the reorientation of the subunits of the complex I under the action of nobiletin. To identify the direct target of the nobiletin in mitochondria, we have designed an affinity column with 3-hydroxynobiletin attached to the Sepharose-4B. Affinity chromatography of mitochondrial membrane extracts revealed one major nobiletin-binding protein with 52 kD and several minor low molecular weight peptides ( Figure 7A , lane b). Western blotting experiments have shown that this major protein is immunostained by the anti-NDUFV1 (NADH dehydrogenase (ubiquinone) flavoprotein 1) antibody ( Figure 7A , lane c). Spectroscopic analysis of this fraction demonstrated the UV-visible absorption spectrum characteristic of a [4Fe-4S] cluster [24] , with an absorption shoulder around 400 nm (data not shown). This protein complex catalyzes the NADH: ubiquinone reductase reaction, which was increased in the presence of nobiletin ( Figure  7B ). These data suggest that nobiletin binds to the NDUFV1 subunit of complex I.
Since complex I is one of the major source of ROS production, the peroxide-forming activity of affinity-purified preparation was determined. We have found that this protein produces peroxides and the formation of ROS increases in the presence of rotenone. The addition of nobiletin significantly decreases rotenone-sensitive, as well as a rotenone-insensitive synthesis of H 2 O 2 . Interestingly that nobiletin eliminates the effect of rotenone after a certain time interval (Figure 8 ). These data confirm the suggestion that nobiletin could change reorientation of complex I subunits.
Nobiletin is an O-methylated flavonoid found in citrus peels that have anticancer, antiviral, neuroprotective, anti-inflammatory activities and, depending on the cell types, exhibits both pro-or anti-apoptotic properties. Nobiletin can suppress the viability of cancer cells in a concentration-dependent manner through multiple pathways (VEGF, HIF-1α, Akt phosphorylation, cMyc, and NF-κB) [25, 26] . At the same time, this compound has an anti-apoptotic effect, since protected neuronal cell death through activation of the cAMP-dependent pathway [10] . This different, pro-and antiapoptotic action of nobiletin indicates that its effect is more complex and involves various intracellular regulatory systems.
Many flavonoids decrease mitochondrial hydrogen peroxide production by inhibition of complex I [27] . In this study, we have found that nobiletin decreases oxygen consumption in the presence of glutamate and malate and increases in the presence of succinate in both resting state and state 3 of electron transport chain. In parallel, nobiletin transitory decreases rotenone-sensitive NADH: coenzyme Q 10 reductase activity, but elevates the α-ketoglutaratedependent production of ATP.
In addition, our data have shown that nobiletin induces transient elevation of membrane potential followed by mild depolarization. Such 'mild mitochondrial uncoupling' stimulus could diminish a detrimental Ca 2+ influx during an excitotoxic insult and protects neurons against oxidative stress [28, 29] . This effect may arise due to the decrease in oxygen consumption under the action of nobiletin. Take into account that nobiletin also increases KGDH/SCS complex activity; this compensatory protective mechanism may underlie the shift in energy metabolism directed to the acceleration of matrix substrate-level phosphorylation. KGDH forms a ternary complex with SCS and NADH: ubiquinone oxidoreductase [30] , supposing that this shift may occur through protein-protein interactions. It could be proposed that during inhibition of the respiratory chain or submaximal uncoupling, matrix substrate-level phosphorylation should be crucial in providing ATP primary level for the reversed F 0 F 1 -ATPase, maintaining membrane potential and prevention cell death [31] . Therefore, nobiletin can act as an 'uncoupler', causing mild depolarization and accelerating matrix substrate-level phosphorylation.
Transient hyperpolarization is accompanied by a temporary increase in the production of peroxides that is observed at 5 minutes of preincubation of nobiletin with mitochondria. Further prolongation of incubation led to the depolarization and decreased the production of peroxide. The precise mechanism involved in nobiletin-dependent transient hyperpolarization is still unclear. In our system, hyperpolarization phase seems to be mediated by reverse-operated oligomycin-sensitive mitochondrial F 1 F 0 -ATPase that is essential for activation of substrate-level phosphorylation. Hyperpolarization phase, preceding mitochondrial depolarization, coincides with the start of the excessive ROS generation that can potentially be explained by a short block of electron transfer in mitochondria [32] . Apparently, transient hyperpolarization and peroxide spikes cause the reprogramming of mitochondrial function underlying the phenomenon, like "ischemic pre-conditions".
To determine the site of nobiletin's action we conducted affinity purification of mitochondrial membrane extracts and found that bound 52 kDa protein has the immunoreactivity against the anti-NDUFV1 antibody. This subunit of NADH: ubiquinone oxidoreductase is localized in the peripheral matrix arm of complex I. NDUFV1 is one of the seven "core subunits" of NADH: ubiquinone oxidoreductase module, catalyzing the oxidation of NADH and electron transfer [33] . Defects in the assembly of "core subunits" module are often observed in various neurodegenerative disorders [34] . This module contains rotenone-insensitive NADH 1836 Natural Product Communications Vol. 11 (12) 2016 Sharikadze et al.
oxidation site that produces ROS [35] and may be a target for different flavonoids [27] .
The mechanism of nobiletin's action on the complex I subunits is unknown. Since nobiletin is a hydrophobic compound and easily penetrates biological membranes, it possibly could change the assembly of the complex I in the mitochondrial matrix, either directly or through other regulatory proteins. Nobiletin, like fatty acids, may interact with neuronal uncoupling proteins (UCP2, UCP4, and UCP5) and attenuates the production of ROS through dissipation of the proton gradient and mild uncoupling [36] . On the other hand, the effect of nobiletin on the uncoupling proteins may be mediated by mitochondrial protein kinase A (PKA). It has been found that nobiletin via cytoplasmic PKA-dependent phosphorylation of synaptic proteins exhibited memory-improving effects in various animal models of dementia [37] . PKA, as well as adenylate cyclase, were found in mitochondria. In the mitochondrial matrix, PKA phosphorylates various subunits of complex I and IV, however, the functional effect of phosphorylation is not entirely clear [38] . PKA-dependent phosphorylation of complex I subunits has been postulated to play a role in complex assembly, while phosphorylation of complex IV is likely exhibited in the regulation of mitochondrial bioenergetics and ROS production [39, 40] . Importantly that mitochondrial adenylate cyclase is activated by carbon dioxide -one of the by-products of α-KGDH reaction [38] . Therefore, activation of α-KGDH complex, which was found in our experiments, may lead to the production of cAMP and subsequent activation of PKA.
It should be noted that the neuroprotective effect of uncoupling protein 2 (UCP2) also requires cAMP-dependent protein kinase [41] . This protein restores a balance toward oxidative phosphorylation in the cancer cell and represses malignant phenotypes [42] . Thus, nobiletin via cAMP/UCP2 could reduce oxygen consumption and peroxide production through complex 1 and, more importantly, cause a reprogramming of mitochondrial metabolism in cancer cells from glycolysis toward succinate-driven oxidative phosphorylation. Further studies are needed to confirm this assumption. Taking into account the strong potential of nobiletin in the correction of cancer cell metabolism, as well as in the regulation of cell viability, understanding of the molecular basis of action of nobiletin would have implications for a therapeutic approach to a wide range of pathologies.
Experimental
Isolation of brain mitochondria: Isolation of cortical bovine brain non-synaptosomal mitochondria was achieved by homogenization of cortex and the following centrifugation at discontinuous 23%/40% Percoll gradient as described [43] . All steps were carried out under ice-cold conditions. Mitochondrial respiration was measured using a Clark-type electrode (OxyGraph Plus, Hansatech, UK). Mitochondria (0.05 mg of protein) were added to 0.5 mL of respiration buffer, consisting of 200 mM sucrose, 25 mM KCl, 2 mM K 2 HPO 4, 5 mM HEPES, pH 7.2, 5 mM MgCl 2 , 0.2 mg/mL of BSA, 30 μM Ap 5 A (an inhibitor of adenylate kinase), 10 mM glutamate, and 5 mM malate or 5mM succinate. To initiate a phosphorylating respiration (State 3), ADP (1 mM, final concentration) was added to the mitochondrial suspension [44] . To determine the activity of the I and II complexes of respiratory chain 2 µM Rotenone and 100µM 3-NPA were added to respiration buffer. ATP production was estimated by the luminometric method. Briefly, 0.1 mg/mL of freshly isolated mitochondria were added to the 10 mM Tris-HCl buffer pH 7.4, containing 0.32 M mannitol, 8 mM inorganic phosphate, 4 mM MgCl 2 , 0.08 mM EDTA, 1mM EGTA, 0.1 mM Ap 5 A, 0.2 mg/mL fatty acid-free BSA). To induce ATP production 10mM glutamate and 5mM malate and 1mM of ADP was added. To estimate the part of ATP production by oxidative phosphorylation 2 μg/mL oligomycin were added. ATP was quantified by luciferin/luciferase assay (Sigma). α-ketoglutarate dependent ATP production was determined in the incubation medium containing 0.1 mg/mL of freshly isolated mitochondria,10 mM Tris-HCl, pH 7.4, 0.32 M mannitol, 20 μg/mL alamethicin, 0.3mM thiamine pyrophosphate (TPP), 0.2mM MgCl 2 , 50µM CaCl 2 , 5mM α-ketoglutarate, 1 µM rotenone, 0.1 mM Ap 5 A, 0.2mM NAD + and 100µM 3-NPA. The reaction was started by the addition of 0.14 mM CoASH. After incubation at 25°C for 5 min, the reaction was stopped and ATP was quantified by luciferin/luciferase assay (Sigma).
Succinyl-CoA-ligase was assessed in 50 mM potassium phosphate buffer pH 7.2, containing 0.4% CHAPS, 10 mM MgCl 2 , 0.2 mM succinyl-CoA, 2 mM ADP and 0.2 mM DTNB. The reactions were initiated by adding succinyl-CoA and DTNB in quick succession. Reaction rates were corrected by subtracting the rate observed when ADP was omitted [45] .
α-ketoglutarate dehydrogenase activity assay was carried out in the reaction medium, consisting 20 mM HEPES (pH 7.8), 0.3 mM thiamine pyrophosphate, 50 μM CaCl 2 , 0.2 mM MgCl 2 , 5 mM αketoglutarate, 1 mM dithiothreitol, and 0.5 mM NAD + [46] . The reaction was started by adding 0.12 mM CoASH to freeze-thawed mitochondria (0.1 mg/mL). Reduction of NAD + was monitored spectrophotometrically at 340 nm.
Mitochondrial membrane potential was measured by using the fluorescence signal of the cationic dye safranine O [47] . Mitochondria (0.2 mg protein/mL) were incubated in 2.5 mL of buffer, containing 5mM HEPES, 5mM MgCl 2 , 2mM KH 2 PO 4 (pH 7.4), 0.1% BSA, 5µM safranine O, and 40 µL mitochondrial fraction. For activation of the respiratory chain, the glutamate and malate were added at final concentration 10mM and 5mM, respectively. Fluorescence was detected with an excitation wavelength of 460 nm and an emission wavelength of 540 nm, during 10 min. Data are reported as arbitrary fluorescence units.
Determination of mitochondrial hydrogen peroxide generation
was assessed by the scopoletin oxidation method. Mitochondria (0.2 mg/mL) were incubated in the 10mM HEPES buffer pH 7.4, containing 5mM MgCl 2 , 2mM KH 2 PO 4 , 250mM Sucrose, 0.1% BSA, 1 unit/mL horseradish peroxidase, 100nM scopoletin. For activation of Complex II the 5mM succinate was used as the substrate, for Complex I -10mM glutamate and 5mM malate. Fluorescence was monitored at excitation and emission wavelengths of 460 nm and 540 nm, respectively, during 5 min. For determination of calcium-induced peroxide formation 0.1mM CaCl 2 and 0.05 mM EGTA were used. To reduce reverse electron transport, 1 M rotenone was added to incubation medium in the case of succinate as substrate.
Mitochondrial protein solubilization:
Cortex from bovine brains was placed in isolation media containing 225 mM mannitol, 75 mM sucrose, 5 mM HEPES buffer, pH 7.3, 1 mg/mL BSA and 0.5 mM EDTA [48] . After centrifugation at 10, 500 x g, the first mitochondrial pellet was treated with digitonin (final concentration of 0.013%). Mitochondria were then resuspended and centrifuged in isolation medium without digitonin. All the isolation procedures were carried out at 0-2 0 C. Proteins solubilization were performed by resuspending of pellet 50 mM Tris-HCl buffer pH 7.0, containing 10% n-dodecyl--D-maltopyranoside and 2mM PMSF, for 30 min on ice. The supernatant was separated from the insoluble material by centrifugation for 90 min at 20,000 x g at 4°C. Detergents from the collected supernatant were removed by dialysis, and final dialysate was subject for following affinity chromatography.
Affinity chromatography of mitochondrial solubilized preparation was performed using nobiletin bound Sepharose as a stationary matrix 3-hydroxynobiletin (3-hydroxy-5,6,7,8,30,40hexamethoxyflavone) was synthesized in one-step by reacting nobiletin with dimethyl dioxirane (DMD) in acetone at low temperature [49] . 3-hydroxynobiletin coupling to Epoxy-activated Sepharose 6B was carried out according to manufacture's protocol (GE Healthcare) with small modifications. Briefly, the ligand was diluted to concentration 100 µmole ligand/mL in coupling buffer (carbonate buffer, pH 11.5) and acetone, mixed with Epoxyactivated Sepharose 6B and incubated for 16 hours at 35°C. Remaining active groups on the gel were blocked by 1M ethanolamine. Obtained ligand-coupled gel was washed with opposite pH buffers (0.1 M acetate buffer pH 4.0 and 0.1 M Tris-HCl pH 8.0) and packed into the column (4x 0.8 cm). Elution of bound substances was performed by 0.5M NaCl solution in starting buffer (20 Mm Tris-HCl, pH 7.4). Eluted fraction was purified from ionic contamination by dialysis and was subject to subsequent analysis. Protein composition of a fraction was determined by SDS-PAGE and the proteins were visualized by Coomassie Brilliant Blue staining.
Western blotting analysis:
For immunoblotting experiments, 50 µg of denatured protein from affinity-purified fraction were separated by SDS-PAGE on 15% gels and transferred to nitrocellulose membranes. After blocking the membranes were incubated with the primary anti-NDUFV1 antibody (ab203208, Abcam). Immunolabeled bands were visualized using enhanced chemiluminescence (Amersham Biosciences) and analyzed by densitometric scanning. The intensities of the bands were within the linear range of the amount of protein loaded. NADH:ubiquinone reductase activity of isolated brain mitochondria and affinity purified preparation was measured spectrophotometrically at 340 nm in an incubation medium containing 25 mM potassium phosphate, 3.5 g/L BSA, 60 μM DCIP, 70 μMCoQ1, and 0.2 mmol/L NADH, pH 7.8. After addition of protein preparation (100µg) or mitochondria (50 µg) the absorbance was measured at 30-s intervals for 4 min at 37°C [50] .
Protein concentration was determined using a BCA Protein Assay kit (Santa Cruz).
Statistical analysis was performed using either an unpaired t test or a one-way ANOVA and Scheffer's posthoc analysis when appropriate. Results were considered significant when p<0.05. The results are expressed as the group means ± SEM from at least three independent experiments.
